HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein.

Abstract
Induction of monocytic differentiation by bryostatin1 (bryo1) conferred on THP-1 leukemia cells the ability to resist Z-LLL-CHO-induced apoptosis. The mechanism of resistance developed during this process was investigated. Apoptosis resistance was associated with an enhanced expression of X-linked inhibitor of apoptosis protein (XIAP), an endogenous caspase inhibitor, in differentiated THP-1 cells. Bryo1 also increased the level of c-IAP-1, yet decreased the level of c-IAP-2 in THP-1 cells, indicating that distinct regulatory mechanisms are operative. In addition, treatment of THP-1 cells with bryo1 induced a rapid and sustained activation of MEK, prior to the upregulation of XIAP and monocytic differentiation. Pretreatment of THP-1 cells with MEK inhibitors (U0126 and PD98059) prior to bryo1 induction blocked the expression of both XIAP and the c-fms product (M-CSF receptor), a hallmark of monocytic differentiation, but not Bcl-2. In addition, the expression of XIAP in bryo1-treated cells was inhibited by CAPE, a NF-kappaB-specific inhibitor, indicating that its expression is under the transcriptional regulation of NF-kappaB downstream of the MEK/MAPK pathway. The importance of XIAP in mediating apoptosis resistance was illustrated in cells transiently transfected with XIAP, which conferred on THP-1 cells the ability to resist Z-LLL-CHO-induced apoptosis. These findings suggest that the expression of XIAP is linked to monocytic differentiation in bryo1-treated THP-1 cells and represents one of the potential antiapoptotic mechanisms acquired during this process.
AuthorsHong Lin, Catheryne Chen, Xiaohua Li, Ben D Chen
JournalExperimental cell research (Exp Cell Res) Vol. 272 Issue 2 Pg. 192-8 (Jan 15 2002) ISSN: 0014-4827 [Print] United States
PMID11777344 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Copyright(c)2002 Elsevier Science.
Chemical References
  • Bryostatins
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • I-kappa B Proteins
  • Lactones
  • Macrolides
  • NF-kappa B
  • NFKBIA protein, human
  • Proteins
  • Proto-Oncogene Proteins
  • X-Linked Inhibitor of Apoptosis Protein
  • XIAP protein, human
  • NF-KappaB Inhibitor alpha
  • bryostatin 1
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase Kinases
Topics
  • Apoptosis
  • Bryostatins
  • Cell Differentiation
  • DNA-Binding Proteins
  • Enzyme Activation
  • Enzyme Inhibitors (metabolism)
  • Gene Expression
  • Humans
  • I-kappa B Proteins
  • Lactones (pharmacology)
  • MAP Kinase Signaling System (physiology)
  • Macrolides
  • Mitogen-Activated Protein Kinase Kinases (metabolism)
  • Mitogen-Activated Protein Kinases (metabolism)
  • Monocytes (cytology, metabolism)
  • NF-KappaB Inhibitor alpha
  • NF-kappa B (metabolism)
  • Protein Biosynthesis
  • Protein Serine-Threonine Kinases
  • Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins (metabolism)
  • Proto-Oncogene Proteins c-akt
  • Tumor Cells, Cultured
  • Up-Regulation
  • X-Linked Inhibitor of Apoptosis Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: